Literature DB >> 921929

Activation of human factor X (Stuart factor) by a protease from Russell's viper venom.

R G Di Scipio, M A Hermodson, E W Davie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 921929     DOI： 10.1021/bi00643a015

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  29 in total

1.  Factor Xa-A pleuripotential protease.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

2.  Ratcheting of the substrate from the zymogen to proteinase conformations directs the sequential cleavage of prothrombin by prothrombinase.

Authors:  Elsa P Bianchini; Steven J Orcutt; Peter Panizzi; Paul E Bock; Sriram Krishnaswamy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

3.  Occlusion of anion-binding exosite 2 in meizothrombin explains its impaired ability to activate factor V.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2018-12-21       Impact factor: 5.157

4.  Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase.

Authors:  Ayse Hacisalihoglu; Peter Panizzi; Paul E Bock; Rodney M Camire; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2007-09-11       Impact factor: 5.157

5.  Prothrombin kringle 1 domain interacts with factor Va during the assembly of prothrombinase complex.

Authors:  H Deguchi; H Takeya; E C Gabazza; J Nishioka; K Suzuki
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

6.  Meizothrombin is an unexpectedly zymogen-like variant of thrombin.

Authors:  Harlan N Bradford; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

7.  Effect of purified Russell's viper venom-factor X activator (RVV-X) on renal hemodynamics, renal functions, and coagulopathy in rats.

Authors:  Montamas Suntravat; Mariem Yusuksawad; Amornpun Sereemaspun; John C Pérez; Issarang Nuchprayoon
Journal:  Toxicon       Date:  2011-06-16       Impact factor: 3.033

8.  Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.

Authors:  Yushi Chikasawa; Keiko Shinozawa; Kagehiro Amano; Kyoichi Ogata; Takeshi Hagiwara; Takashi Suzuki; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2014-07-27       Impact factor: 2.490

9.  A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.

Authors:  Genmin Lu; Francis R DeGuzman; Stanley J Hollenbach; Mark J Karbarz; Keith Abe; Gail Lee; Peng Luan; Athiwat Hutchaleelaha; Mayuko Inagaki; Pamela B Conley; David R Phillips; Uma Sinha
Journal:  Nat Med       Date:  2013-03-03       Impact factor: 53.440

10.  Activation of human factor IX (Christmas factor).

Authors:  R G Di Scipio; K Kurachi; E W Davie
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.